APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Albumin (as Excipient)

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

Selected research

Market Structure

Global Albumin (as Excipient) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17396156031 January 2026192 pages

Choose your research edition.

Industry ResearchAlbumin (as Excipient) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Albumin (as Excipient) Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Albumin (as Excipient) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albumin (as Excipient) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Albumin (as Excipient) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.

By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

Read the full market overview

This report provides an overview of the global Albumin (as Excipient) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Albumin (as Excipient) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Albumin (as Excipient) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albumin (as Excipient) market size, projected growth trends, production technologies, key applications, and end-use industries.

Albumin (as Excipient) Segment by Company

CSL

Grifols

Takeda

Octapharma

Hualan Bio

CBPO

Shanghai RAAS

Kedrion

LFB Group

Albumedix

Biotest

Merck

Ventria (InVitria)

HiMedia

Albumin (as Excipient) Segment by Type

Human Serum Albumin

Recombinant Albumin

Albumin (as Excipient) Segment by Application

Cell Culture Media

Medical Supplements

Therapeutics

Albumin (as Excipient) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin (as Excipient) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albumin (as Excipient) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin (as Excipient).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Albumin (as Excipient) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Albumin (as Excipient) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Albumin (as Excipient) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Albumin (as Excipient) Industry Trends Table 2. Albumin (as Excipient) Industry Drivers Table 3. Albumin (as Excipient) Industry Opportunities and Challenges Table 4. Albumin (as Excipient) Industry Restraints Table 5. Global Albumin (as Excipient) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Albumin (as Excipient) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Albumin (as Excipient) Sales by Manufacturers (MT) & (2021-2026) Table 8. Global Albumin (as Excipient) Sales Market Share by Manufacturers Table 9. Global Albumin (as Excipient) Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Albumin (as Excipient) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Albumin (as Excipient) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Albumin (as Excipient) Manufacturers, Product Type & Application Table 13. Global Albumin (as Excipient) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Albumin (as Excipient) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Human Serum Albumin Table 17. Major Manufacturers of Recombinant Albumin Table 18. Global Albumin (as Excipient) Sales by Type 2021 VS 2025 VS 2032 (MT) Table 19. Global Albumin (as Excipient) Sales by Type (2021-2026) & (MT) Table 20. Global Albumin (as Excipient) Sales by Type (2027-2032) & (MT) Table 21. Global Albumin (as Excipient) Sales Market Share by Type (2021-2026) Table 22. Global Albumin (as Excipient) Sales Market Share by Type (2027-2032) Table 23. Global Albumin (as Excipient) Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 24. Global Albumin (as Excipient) Revenue by Type (2021-2026) & (MT) Table 25. Global Albumin (as Excipient) Revenue by Type (2027-2032) & (MT) Table 26. Global Albumin (as Excipient) Revenue Market Share by Type (2021-2026) Table 27. Global Albumin (as Excipient) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cell Culture Media Table 29. Major Manufacturers of Medical Supplements Table 30. Major Manufacturers of Therapeutics Table 31. Global Albumin (as Excipient) Sales by Application 2021 VS 2025 VS 2032 (MT) Table 32. Global Albumin (as Excipient) Sales by Application (2021-2026) & (MT) Table 33. Global Albumin (as Excipient) Sales by Application (2027-2032) & (MT) Table 34. Global Albumin (as Excipient) Sales Market Share by Application (2021-2026) Table 35. Global Albumin (as Excipient) Sales Market Share by Application (2027-2032) Table 36. Global Albumin (as Excipient) Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 37. Global Albumin (as Excipient) Revenue by Application (2021-2026) & (MT) Table 38. Global Albumin (as Excipient) Revenue by Application (2027-2032) & (MT) Table 39. Global Albumin (as Excipient) Revenue Market Share by Application (2021-2026) Table 40. Global Albumin (as Excipient) Revenue Market Share by Application (2027-2032) Table 41. Global Albumin (as Excipient) Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 42. Global Albumin (as Excipient) Sales by Region (2021-2026) & (MT) Table 43. Global Albumin (as Excipient) Sales Market Share by Region (2021-2026) Table 44. Global Albumin (as Excipient) Sales Forecasted by Region (2027-2032) & (MT) Table 45. Global Albumin (as Excipient) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Albumin (as Excipient) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 47. North America Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 48. North America Albumin (as Excipient) Sales by Country (2027-2032) & (MT) Table 49. Europe Albumin (as Excipient) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 50. Europe Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 51. Europe Albumin (as Excipient) Sales by Country (2027-2032) & (MT) Table 52. Asia Pacific Albumin (as Excipient) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 53. Asia Pacific Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 54. Asia Pacific Albumin (as Excipient) Sales by Country (2027-2032) & (MT) Table 55. South America, Middle East and Africa Albumin (as Excipient) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 56. South America, Middle East and Africa Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 57. South America, Middle East and Africa Albumin (as Excipient) Sales by Country (2027-2032) & (MT) Table 58. Global Albumin (as Excipient) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Albumin (as Excipient) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Albumin (as Excipient) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Albumin (as Excipient) Revenue Market Share by Region (2021-2026) Table 62. Global Albumin (as Excipient) Revenue Market Share by Region (2027-2032) Table 63. CSL Company Information Table 64. CSL Business Overview Table 65. CSL Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. CSL Albumin (as Excipient) Product Portfolio Table 67. CSL Recent Development Table 68. Grifols Company Information Table 69. Grifols Business Overview Table 70. Grifols Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Grifols Albumin (as Excipient) Product Portfolio Table 72. Grifols Recent Development Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Takeda Albumin (as Excipient) Product Portfolio Table 77. Takeda Recent Development Table 78. Octapharma Company Information Table 79. Octapharma Business Overview Table 80. Octapharma Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Octapharma Albumin (as Excipient) Product Portfolio Table 82. Octapharma Recent Development Table 83. Hualan Bio Company Information Table 84. Hualan Bio Business Overview Table 85. Hualan Bio Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hualan Bio Albumin (as Excipient) Product Portfolio Table 87. Hualan Bio Recent Development Table 88. CBPO Company Information Table 89. CBPO Business Overview Table 90. CBPO Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. CBPO Albumin (as Excipient) Product Portfolio Table 92. CBPO Recent Development Table 93. Shanghai RAAS Company Information Table 94. Shanghai RAAS Business Overview Table 95. Shanghai RAAS Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanghai RAAS Albumin (as Excipient) Product Portfolio Table 97. Shanghai RAAS Recent Development Table 98. Kedrion Company Information Table 99. Kedrion Business Overview Table 100. Kedrion Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Kedrion Albumin (as Excipient) Product Portfolio Table 102. Kedrion Recent Development Table 103. LFB Group Company Information Table 104. LFB Group Business Overview Table 105. LFB Group Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. LFB Group Albumin (as Excipient) Product Portfolio Table 107. LFB Group Recent Development Table 108. Albumedix Company Information Table 109. Albumedix Business Overview Table 110. Albumedix Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Albumedix Albumin (as Excipient) Product Portfolio Table 112. Albumedix Recent Development Table 113. Biotest Company Information Table 114. Biotest Business Overview Table 115. Biotest Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Biotest Albumin (as Excipient) Product Portfolio Table 117. Biotest Recent Development Table 118. Merck Company Information Table 119. Merck Business Overview Table 120. Merck Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Merck Albumin (as Excipient) Product Portfolio Table 122. Merck Recent Development Table 123. Ventria (InVitria) Company Information Table 124. Ventria (InVitria) Business Overview Table 125. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Ventria (InVitria) Albumin (as Excipient) Product Portfolio Table 127. Ventria (InVitria) Recent Development Table 128. HiMedia Company Information Table 129. HiMedia Business Overview Table 130. HiMedia Albumin (as Excipient) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. HiMedia Albumin (as Excipient) Product Portfolio Table 132. HiMedia Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Albumin (as Excipient) Distributors List Table 136. Albumin (as Excipient) Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Albumin (as Excipient) Product Image Figure 2. Global Albumin (as Excipient) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albumin (as Excipient) Market Size (2021-2032) & (US$ Million) Figure 4. Global Albumin (as Excipient) Sales (2021-2032) & (MT) Figure 5. Global Albumin (as Excipient) Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Albumin (as Excipient) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Human Serum Albumin Image Figure 9. Recombinant Albumin Image Figure 10. Global Albumin (as Excipient) Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 11. Global Albumin (as Excipient) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Albumin (as Excipient) Sales Market Share by Type (2021-2032) Figure 13. Global Albumin (as Excipient) Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 14. Global Albumin (as Excipient) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Albumin (as Excipient) Revenue Market Share by Type (2021-2032) Figure 16. Cell Culture Media Image Figure 17. Medical Supplements Image Figure 18. Therapeutics Image Figure 19. Global Albumin (as Excipient) Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 20. Global Albumin (as Excipient) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Albumin (as Excipient) Sales Market Share by Application (2021-2032) Figure 22. Global Albumin (as Excipient) Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 23. Global Albumin (as Excipient) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Albumin (as Excipient) Revenue Market Share by Application (2021-2032) Figure 25. North America Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 26. North America Albumin (as Excipient) Sales Market Share by Country (2021-2032) Figure 27. U.S. Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 28. Canada Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 29. Mexico Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 30. Europe Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 31. Europe Albumin (as Excipient) Sales Market Share by Country (2021-2032) Figure 32. Germany Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 33. France Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 34. U.K. Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 35. Italy Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 36. Netherlands Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 37. Asia Pacific Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 38. Asia Pacific Albumin (as Excipient) Sales Market Share by Country (2021-2032) Figure 39. China Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 40. Japan Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 41. South Korea Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 42. Southeast Asia Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 43. India Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 44. Australia Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 45. South America, Middle East and Africa Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 46. South America, Middle East and Africa Albumin (as Excipient) Sales Market Share by Country (2021-2032) Figure 47. Brazil Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 48. South Africa Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 49. Saudi Arabia Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 50. Turkey Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 51. Argentina Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 52. UAE Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 53. Egypt Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 54. Chile Albumin (as Excipient) Sales and Growth Rate (2021-2032) & (MT) Figure 55. Global Albumin (as Excipient) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Albumin (as Excipient) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Albumin (as Excipient) Revenue (2021-2032) & (US$ Million) Figure 58. North America Albumin (as Excipient) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Albumin (as Excipient) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Albumin (as Excipient) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Albumin (as Excipient) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Albumin (as Excipient) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Albumin (as Excipient) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Albumin (as Excipient) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Albumin (as Excipient) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Albumin (as Excipient) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Human Serum Albumin
  • Recombinant Albumin
Applications
  • Cell Culture Media
  • Medical Supplements
  • Therapeutics
Companies covered
  • CSL
  • Grifols
  • Takeda
  • Octapharma
  • Hualan Bio
  • CBPO
  • Shanghai RAAS
  • Kedrion
  • LFB Group
  • Albumedix
  • Biotest
  • Merck
  • Ventria (InVitria)
  • HiMedia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Albumin (as Excipient) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Albumin (as Excipient) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Albumin (as Excipient) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Albumin (as Excipient) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Albumin (as Excipient) Market Dynamics
  1. 2.1 Albumin (as Excipient) Industry Trends
  2. 2.2 Albumin (as Excipient) Industry Drivers
  3. 2.3 Albumin (as Excipient) Industry Opportunities and Challenges
  4. 2.4 Albumin (as Excipient) Industry Restraints
3 Albumin (as Excipient) Market by Manufacturers
  1. 3.1 Global Albumin (as Excipient) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Albumin (as Excipient) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Albumin (as Excipient) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Albumin (as Excipient) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Albumin (as Excipient) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Albumin (as Excipient) Manufacturers, Product Type & Application
  7. 3.7 Global Albumin (as Excipient) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Albumin (as Excipient) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Albumin (as Excipient) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Albumin (as Excipient) Tier 1, Tier 2, and Tier 3
4 Albumin (as Excipient) Market by Type
  1. 4.1 Albumin (as Excipient) Type Introduction
  2. 4.1.1 Human Serum Albumin
  3. 4.1.2 Recombinant Albumin
  4. 4.2 Global Albumin (as Excipient) Sales by Type
  5. 4.2.1 Global Albumin (as Excipient) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Albumin (as Excipient) Sales by Type (2021-2032)
  7. 4.2.3 Global Albumin (as Excipient) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Albumin (as Excipient) Revenue by Type
  9. 4.3.1 Global Albumin (as Excipient) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Albumin (as Excipient) Revenue by Type (2021-2032)
  11. 4.3.3 Global Albumin (as Excipient) Revenue Market Share by Type (2021-2032)
5 Albumin (as Excipient) Market by Application
  1. 5.1 Albumin (as Excipient) Application Introduction
  2. 5.1.1 Cell Culture Media
  3. 5.1.2 Medical Supplements
  4. 5.1.3 Therapeutics
  5. 5.2 Global Albumin (as Excipient) Sales by Application
  6. 5.2.1 Global Albumin (as Excipient) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Albumin (as Excipient) Sales by Application (2021-2032)
  8. 5.2.3 Global Albumin (as Excipient) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Albumin (as Excipient) Revenue by Application
  10. 5.3.1 Global Albumin (as Excipient) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Albumin (as Excipient) Revenue by Application (2021-2032)
  12. 5.3.3 Global Albumin (as Excipient) Revenue Market Share by Application (2021-2032)
6 Global Albumin (as Excipient) Sales by Region
  1. 6.1 Global Albumin (as Excipient) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Albumin (as Excipient) Sales by Region (2021-2032)
  3. 6.2.1 Global Albumin (as Excipient) Sales by Region (2021-2026)
  4. 6.2.2 Global Albumin (as Excipient) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Albumin (as Excipient) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Albumin (as Excipient) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Albumin (as Excipient) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Albumin (as Excipient) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Albumin (as Excipient) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Albumin (as Excipient) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Albumin (as Excipient) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Albumin (as Excipient) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Albumin (as Excipient) Revenue by Region
  1. 7.1 Global Albumin (as Excipient) Revenue by Region
  2. 7.1.1 Global Albumin (as Excipient) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Albumin (as Excipient) Revenue by Region (2021-2026)
  4. 7.1.3 Global Albumin (as Excipient) Revenue by Region (2027-2032)
  5. 7.1.4 Global Albumin (as Excipient) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Albumin (as Excipient) Revenue (2021-2032)
  8. 7.2.2 North America Albumin (as Excipient) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Albumin (as Excipient) Revenue (2021-2032)
  11. 7.3.2 Europe Albumin (as Excipient) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Albumin (as Excipient) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Albumin (as Excipient) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Albumin (as Excipient) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Albumin (as Excipient) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL
  2. 8.1.1 CSL Company Information
  3. 8.1.2 CSL Business Overview
  4. 8.1.3 CSL Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Albumin (as Excipient) Product Portfolio
  6. 8.1.5 CSL Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Albumin (as Excipient) Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 Takeda
  14. 8.3.1 Takeda Company Information
  15. 8.3.2 Takeda Business Overview
  16. 8.3.3 Takeda Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Albumin (as Excipient) Product Portfolio
  18. 8.3.5 Takeda Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Albumin (as Excipient) Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Hualan Bio
  26. 8.5.1 Hualan Bio Company Information
  27. 8.5.2 Hualan Bio Business Overview
  28. 8.5.3 Hualan Bio Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hualan Bio Albumin (as Excipient) Product Portfolio
  30. 8.5.5 Hualan Bio Recent Developments
  31. 8.6 CBPO
  32. 8.6.1 CBPO Company Information
  33. 8.6.2 CBPO Business Overview
  34. 8.6.3 CBPO Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CBPO Albumin (as Excipient) Product Portfolio
  36. 8.6.5 CBPO Recent Developments
  37. 8.7 Shanghai RAAS
  38. 8.7.1 Shanghai RAAS Company Information
  39. 8.7.2 Shanghai RAAS Business Overview
  40. 8.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai RAAS Albumin (as Excipient) Product Portfolio
  42. 8.7.5 Shanghai RAAS Recent Developments
  43. 8.8 Kedrion
  44. 8.8.1 Kedrion Company Information
  45. 8.8.2 Kedrion Business Overview
  46. 8.8.3 Kedrion Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kedrion Albumin (as Excipient) Product Portfolio
  48. 8.8.5 Kedrion Recent Developments
  49. 8.9 LFB Group
  50. 8.9.1 LFB Group Company Information
  51. 8.9.2 LFB Group Business Overview
  52. 8.9.3 LFB Group Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LFB Group Albumin (as Excipient) Product Portfolio
  54. 8.9.5 LFB Group Recent Developments
  55. 8.10 Albumedix
  56. 8.10.1 Albumedix Company Information
  57. 8.10.2 Albumedix Business Overview
  58. 8.10.3 Albumedix Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Albumedix Albumin (as Excipient) Product Portfolio
  60. 8.10.5 Albumedix Recent Developments
  61. 8.11 Biotest
  62. 8.11.1 Biotest Company Information
  63. 8.11.2 Biotest Business Overview
  64. 8.11.3 Biotest Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biotest Albumin (as Excipient) Product Portfolio
  66. 8.11.5 Biotest Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Albumin (as Excipient) Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Ventria (InVitria)
  74. 8.13.1 Ventria (InVitria) Company Information
  75. 8.13.2 Ventria (InVitria) Business Overview
  76. 8.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ventria (InVitria) Albumin (as Excipient) Product Portfolio
  78. 8.13.5 Ventria (InVitria) Recent Developments
  79. 8.14 HiMedia
  80. 8.14.1 HiMedia Company Information
  81. 8.14.2 HiMedia Business Overview
  82. 8.14.3 HiMedia Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 HiMedia Albumin (as Excipient) Product Portfolio
  84. 8.14.5 HiMedia Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Albumin (as Excipient) Value Chain Analysis
  2. 9.1.1 Albumin (as Excipient) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Albumin (as Excipient) Production Mode & Process
  6. 9.2 Albumin (as Excipient) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Albumin (as Excipient) Distributors
  9. 9.2.3 Albumin (as Excipient) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst